http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1292472-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_931b512548a69538889978212d6104bb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-4084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5728
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-40
filingDate 1970-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_713a770d11e53db20c1090e50efff43b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bdad0401c49a4548862b649656a540f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeb0cd931b3cb6eab4f2c26f9604a88d
publicationDate 1972-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1292472-A
titleOfInvention Esters of diphenolic substances
abstract 1292472 Esters of diphenols SPA-SOC PRODOTTI ANTIBIOTICI SpA 10 June 1971 [16 June 1970] 29047/70 Headings C2C and C2P Novel compounds (I) (including salts thereof) where R 1 is H or C 1 to C 6 alkyl, R 2 is C 1 to C 6 alkyl or a heterocycle or CR 1 R 2 signifies a saturated or unsaturated carbocyclic or heterocyclic radical, R 3 is a polybasic inorganic acid residue (e.g. derived from sulphuric, phosphoric or sulphurous acid) and R 4 is H, acyl or R 3 with the proviso that R 4 is not sulpho when R 3 is sulpho and CR 1 R 2 signifies isopropylidene, 2-picolylidene or 3-phthalidylidene, are made by esterifying either the corresponding di - hydroxy compounds or the related dihydroxy compounds carrying halo substituent(s) on the benzene rings and which are adjacent to the hydroxy groups, in which case the halogen atom(s) are subsequently removed. Pharmaceutical preparations having laxative action contain (I) as active ingredient; administration may be orally, rectally or parenterally.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008071387-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4053483-A
priorityDate 1970-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455904803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410932322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1100
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118

Total number of triples: 34.